New York State Teachers Retirement System Has $25.68 Million Position in Humana Inc. (NYSE:HUM)

New York State Teachers Retirement System trimmed its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 6.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 101,201 shares of the insurance provider's stock after selling 6,764 shares during the quarter. New York State Teachers Retirement System owned approximately 0.08% of Humana worth $25,676,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the company. Creative Financial Designs Inc. ADV lifted its position in shares of Humana by 244.0% during the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider's stock worth $27,000 after purchasing an additional 61 shares in the last quarter. Ashton Thomas Securities LLC acquired a new position in shares of Humana during the third quarter worth approximately $31,000. Your Advocates Ltd. LLP lifted its position in shares of Humana by 81.8% during the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider's stock worth $32,000 after purchasing an additional 45 shares in the last quarter. Atwood & Palmer Inc. lifted its position in shares of Humana by 64.5% during the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock worth $39,000 after purchasing an additional 60 shares in the last quarter. Finally, LRI Investments LLC lifted its position in shares of Humana by 1,021.4% during the third quarter. LRI Investments LLC now owns 157 shares of the insurance provider's stock worth $50,000 after purchasing an additional 143 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on HUM. Cantor Fitzgerald reiterated a "neutral" rating and set a $290.00 target price on shares of Humana in a research report on Wednesday, February 12th. Truist Financial increased their price objective on shares of Humana from $260.00 to $290.00 and gave the company a "hold" rating in a report on Monday, January 6th. Morgan Stanley cut their price objective on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a report on Wednesday, February 12th. JPMorgan Chase & Co. cut their price objective on shares of Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a report on Tuesday. Finally, Barclays increased their price objective on shares of Humana from $255.00 to $270.00 and gave the company an "equal weight" rating in a report on Thursday, February 13th. Nineteen analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $285.68.

Insider Activity at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the firm's stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares of the company's stock, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.29% of the stock is owned by insiders.

Humana Stock Up 3.2 %

Shares of HUM stock traded up $8.30 during trading hours on Wednesday, hitting $265.54. 1,233,122 shares of the company were exchanged, compared to its average volume of 1,691,700. The business has a 50 day moving average of $270.05 and a two-hundred day moving average of $291.47. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46. The company has a market capitalization of $31.97 billion, a PE ratio of 26.69, a PEG ratio of 1.91 and a beta of 0.56.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Analysts anticipate that Humana Inc. will post 16.49 earnings per share for the current fiscal year.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.